Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Kälber KA"'
Autor:
Kälber KA; Universitäts-Hautklinik Heidelberg, Ruprecht-Karls Universität Heidelberg, Im Neuenheimer Feld 440, 69120, Heidelberg, Deutschland. katharinaanna.kaelber@med.uni-heidelberg.de., Enk A; Universitäts-Hautklinik Heidelberg, Ruprecht-Karls Universität Heidelberg, Im Neuenheimer Feld 440, 69120, Heidelberg, Deutschland., Michel J; ZBS 1: Hochpathogene Viren & Konsiliarlabor für Pockenviren, Robert Koch-Institut, Berlin, Deutschland., Schrick L; ZBS 1: Hochpathogene Viren & Konsiliarlabor für Pockenviren, Robert Koch-Institut, Berlin, Deutschland., Winkler JK; Universitäts-Hautklinik Heidelberg, Ruprecht-Karls Universität Heidelberg, Im Neuenheimer Feld 440, 69120, Heidelberg, Deutschland.
Publikováno v:
Dermatologie (Heidelberg, Germany) [Dermatologie (Heidelb)] 2024 Sep 04. Date of Electronic Publication: 2024 Sep 04.
Autor:
Kälber KA; Universitäts-Hautklinik Heidelberg, Ruprecht-Karls-Universität Heidelberg., Enk A; Universitäts-Hautklinik Heidelberg, Ruprecht-Karls-Universität Heidelberg., Hartmann M; Universitäts-Hautklinik Heidelberg, Ruprecht-Karls-Universität Heidelberg.
Publikováno v:
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG [J Dtsch Dermatol Ges] 2024 Jul; Vol. 22 (7), pp. 1006-1007.
Autor:
Kälber KA; Universitäts-Hautklinik Heidelberg, Ruprecht-Karls Universität Heidelberg, Im Neuenheimer Feld 440, 69120, Heidelberg, Deutschland. katharinaanna.kaelber@med.uni-heidelberg.de., Winkler JK; Universitäts-Hautklinik Heidelberg, Ruprecht-Karls Universität Heidelberg, Im Neuenheimer Feld 440, 69120, Heidelberg, Deutschland., Toberer F; Universitäts-Hautklinik Heidelberg, Ruprecht-Karls Universität Heidelberg, Im Neuenheimer Feld 440, 69120, Heidelberg, Deutschland., Stojković M; Universitätsklinikum Heidelberg Sektion Infektiologie und Tropenmedizin, Ruprecht-Karls Universität Heidelberg, Heidelberg, Deutschland., Mechtersheimer G; Universitätsklinikum Heidelberg Pathologisches Institut, Abteilung Allgemeine Pathologie und Pathologische Anatomie, Ruprecht-Karls Universität Heidelberg, Heidelberg, Deutschland., Hoffmann J; Universitäts-Hautklinik Heidelberg, Ruprecht-Karls Universität Heidelberg, Im Neuenheimer Feld 440, 69120, Heidelberg, Deutschland.
Publikováno v:
Dermatologie (Heidelberg, Germany) [Dermatologie (Heidelb)] 2024 Jul; Vol. 75 (7), pp. 592-594. Date of Electronic Publication: 2024 Feb 28.
Autor:
Kälber KA; Universitäts-Hautklinik Heidelberg, Ruprecht-Karls Universität Heidelberg., Winkler JK; Universitäts-Hautklinik Heidelberg, Ruprecht-Karls Universität Heidelberg., Toberer F; Universitäts-Hautklinik Heidelberg, Ruprecht-Karls Universität Heidelberg., Wardelmann E; Universitätsklinikum Münster, Gerhard-Domagk-Institut für Pathologie, Münster., Hartschuh W; Universitäts-Hautklinik Heidelberg, Ruprecht-Karls Universität Heidelberg.; Hautarztpraxis Durani, Heidelberg.
Publikováno v:
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG [J Dtsch Dermatol Ges] 2024 Feb; Vol. 22 (2), pp. 295-299. Date of Electronic Publication: 2024 Jan 02.
Autor:
Walle T; Clinical Cooperation Unit Virotherapy, German Cancer Research Center (DKFZ), Heidelberg, Germany. t.walle@dkfz.de.; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany. t.walle@dkfz.de.; German Cancer Consortium (DKTK), Heidelberg, Germany. t.walle@dkfz.de., Bajaj S; Clinical Cooperation Unit Virotherapy, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Kraske JA; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Rösner T; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Cussigh CS; Department of Dermatology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Kälber KA; Department of Dermatology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Müller LJ; Department of Hematology, University Hospital Heidelberg, Heidelberg, Germany., Strobel SB; Department of Dermatology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Burghaus J; Department of Dermatology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Kallenberger SM; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Stein-Thöringer CK; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.; Division Microbiome and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany., Jenzer M; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Schubert A; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; BioQuant & Department of Cell and Molecular Biology, Heidelberg University, Heidelberg, Germany.; Division Signaling and Functional Genomics, German Cancer Research Center (DKFZ), Heidelberg, Germany., Kahle S; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Williams A; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Hoyler B; Clinical Cooperation Unit Virotherapy, German Cancer Research Center (DKFZ), Heidelberg, Germany., Zielske L; NCT Liquid Biobank, National Center for Tumor Diseases (NCT), Heidelberg, Germany., Skatula R; NCT Liquid Biobank, National Center for Tumor Diseases (NCT), Heidelberg, Germany., Sawall S; Clinical Cooperation Unit Virotherapy, German Cancer Research Center (DKFZ), Heidelberg, Germany., Leber MF; Clinical Cooperation Unit Virotherapy, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Kunes RZ; Department of Statistics, Columbia University, New York, NY, USA., Krisam J; Institute of Medical Biometry, Heidelberg University, Heidelberg, Germany., Fremd C; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.; Division of Gynecological Oncology, National Center for Tumor Diseases (NCT), Heidelberg, Germany., Schneeweiss A; Division of Gynecological Oncology, National Center for Tumor Diseases (NCT), Heidelberg, Germany., Krauss J; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Apostolidis L; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Berger AK; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Haag GM; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Applied Tumor-Immunity, German Cancer Research Center (DKFZ), Heidelberg, Germany., Zschäbitz S; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Halama N; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.; Department of Translational Immunotherapy, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Helmholtz Institute for Translational Oncology (HITRON), Mainz, Germany., Springfeld C; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Kirsten R; NCT Liquid Biobank, National Center for Tumor Diseases (NCT), Heidelberg, Germany., Hassel JC; Department of Dermatology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Jäger D; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Applied Tumor-Immunity, German Cancer Research Center (DKFZ), Heidelberg, Germany., Ungerechts G; Clinical Cooperation Unit Virotherapy, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.; CanVirex, Heidelberg, Germany.; Ottawa Hospital Research Institute, Cancer Therapeutics Program, Ottawa, Ontario, Canada.
Publikováno v:
Nature cancer [Nat Cancer] 2022 Sep; Vol. 3 (9), pp. 1137.
Autor:
Walle T; Clinical Cooperation Unit Virotherapy, German Cancer Research Center (DKFZ), Heidelberg, Germany. t.walle@dkfz.de.; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany. t.walle@dkfz.de.; German Cancer Consortium (DKTK), Heidelberg, Germany. t.walle@dkfz.de., Bajaj S; Clinical Cooperation Unit Virotherapy, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Kraske JA; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Rösner T; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Cussigh CS; Department of Dermatology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Kälber KA; Department of Dermatology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Müller LJ; Department of Hematology, University Hospital Heidelberg, Heidelberg, Germany., Strobel SB; Department of Dermatology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Burghaus J; Department of Dermatology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Kallenberger SM; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Stein-Thöringer CK; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.; Division Microbiome and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany., Jenzer M; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Schubert A; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; BioQuant & Department of Cell and Molecular Biology, Heidelberg University, Heidelberg, Germany.; Division Signaling and Functional Genomics, German Cancer Research Center (DKFZ), Heidelberg, Germany., Kahle S; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Williams A; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Hoyler B; Clinical Cooperation Unit Virotherapy, German Cancer Research Center (DKFZ), Heidelberg, Germany., Zielske L; NCT Liquid Biobank, National Center for Tumor Diseases (NCT), Heidelberg, Germany., Skatula R; NCT Liquid Biobank, National Center for Tumor Diseases (NCT), Heidelberg, Germany., Sawall S; Clinical Cooperation Unit Virotherapy, German Cancer Research Center (DKFZ), Heidelberg, Germany., Leber MF; Clinical Cooperation Unit Virotherapy, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Kunes RZ; Department of Statistics, Columbia University, New York, NY, USA., Krisam J; Institute of Medical Biometry, Heidelberg University, Heidelberg, Germany., Fremd C; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.; Division of Gynecological Oncology, National Center for Tumor Diseases (NCT), Heidelberg, Germany., Schneeweiss A; Division of Gynecological Oncology, National Center for Tumor Diseases (NCT), Heidelberg, Germany., Krauss J; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Apostolidis L; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Berger AK; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Haag GM; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Applied Tumor-Immunity, German Cancer Research Center (DKFZ), Heidelberg, Germany., Zschäbitz S; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Halama N; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.; Department of Translational Immunotherapy, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Helmholtz Institute for Translational Oncology (HITRON), Mainz, Germany., Springfeld C; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Kirsten R; NCT Liquid Biobank, National Center for Tumor Diseases (NCT), Heidelberg, Germany., Hassel JC; Department of Dermatology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Jäger D; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Applied Tumor-Immunity, German Cancer Research Center (DKFZ), Heidelberg, Germany., Ungerechts G; Clinical Cooperation Unit Virotherapy, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.; CanVirex, Heidelberg, Germany.; Ottawa Hospital Research Institute, Cancer Therapeutics Program, Ottawa, Ontario, Canada.
Publikováno v:
Nature cancer [Nat Cancer] 2022 Sep; Vol. 3 (9), pp. 1039-1051. Date of Electronic Publication: 2022 Jun 17.
Autor:
Mitri F; Department of Dermatology, University Hospital Heidelberg, Heidelberg, Germany., Kälber KA; Department of Dermatology, University Hospital Heidelberg, Heidelberg, Germany., Enk AH; Department of Dermatology, University Hospital Heidelberg, Heidelberg, Germany., Toberer F; Department of Dermatology, University Hospital Heidelberg, Heidelberg, Germany.
Publikováno v:
Case reports in dermatology [Case Rep Dermatol] 2022 Aug 31; Vol. 14 (2), pp. 253-256. Date of Electronic Publication: 2022 Aug 31 (Print Publication: 2022).
Autor:
Strobel SB; Department of Dermatology and National Center for Tumor Diseases, University Hospital Heidelberg, Im Neuenheimer Feld 460, 69120, Heidelberg, Germany. sophia.strobel@med.uni-heidelberg.de., Machiraju D; Department of Dermatology and National Center for Tumor Diseases, University Hospital Heidelberg, Im Neuenheimer Feld 460, 69120, Heidelberg, Germany., Kälber KA; Department of Dermatology and National Center for Tumor Diseases, University Hospital Heidelberg, Im Neuenheimer Feld 460, 69120, Heidelberg, Germany., Hassel JC; Department of Dermatology and National Center for Tumor Diseases, University Hospital Heidelberg, Im Neuenheimer Feld 460, 69120, Heidelberg, Germany.
Publikováno v:
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2022 Aug; Vol. 71 (8), pp. 2051-2056. Date of Electronic Publication: 2021 Dec 23.